Biotech Distilled
133 companies · 839 active programs
Substack ↗
Subscribe
Therapeutic Areas
Modalities
Phases
Targets
Companies
Home
›
Targets
› IRAK4
IRAK4
(2 companies · 3 programs)
Companies with an active program directed at IRAK4.
Kymera Therapeutics, Inc.
KYMR
KT-485
Preclinical
KT-485
Nurix Therapeutics, Inc.
NRIX
NX-0479
Phase 1